CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson’s Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson’s Disease
Authors
Keywords
-
Journal
CELLULAR AND MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-27
DOI
10.1007/s10571-019-00761-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanistic Interplay between Autophagy and Apoptotic Signaling in Endosulfan-induced Dopaminergic Neurotoxicity: Relevance to the Adverse Outcome Pathway in Pesticide Neurotoxicity
- (2019) Chunjuan Song et al. TOXICOLOGICAL SCIENCES
- Immune system and new avenues in Parkinson’s disease research and treatment
- (2019) Ava Nasrolahi et al. REVIEWS IN THE NEUROSCIENCES
- Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson’s Disease
- (2019) Jie Luo et al. Journal of Neuroimmune Pharmacology
- CRISPR Cpf1 proteins: structure, function and implications for genome editing
- (2019) Fatemeh Safari et al. Cell and Bioscience
- Cytogenetic Analysis of the Results of Genome Editing on the Cell Model of Parkinson’s Disease
- (2018) A. S. Vetchinova et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene
- (2018) X. Shawn Liu et al. CELL
- Knockdown of the mitochondria‐localized protein p13 protects against experimental parkinsonism
- (2018) Naoki Inoue et al. EMBO REPORTS
- Parkin function in Parkinson's disease
- (2018) Connor Arkinson et al. SCIENCE
- Generation of RAB39B knockout isogenic human embryonic stem cell lines to model RAB39B- mediated Parkinson's disease
- (2018) Yujing Gao et al. Stem Cell Research
- Sam50 Regulates PINK1-Parkin-Mediated Mitophagy by Controlling PINK1 Stability and Mitochondrial Morphology
- (2018) Fenglei Jian et al. Cell Reports
- Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction
- (2018) Yukari Suda et al. Molecular Brain
- Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease
- (2018) Desiree A. Piper et al. Frontiers in Neuroscience
- Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes
- (2018) Matthew Neal et al. GLIA
- Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
- (2018) Boris Kantor et al. MOLECULAR THERAPY
- Animal models of neurodegenerative diseases
- (2018) Ted M. Dawson et al. NATURE NEUROSCIENCE
- CRISPR-Cas guides the future of genetic engineering
- (2018) Gavin J. Knott et al. SCIENCE
- CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson’s Disease
- (2018) Xiang-Xing Zhu et al. Scientific Reports
- Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene
- (2018) Yixi Chen et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Testing the MDS clinical diagnostic criteria for Parkinson's disease
- (2018) Anette Schrag MOVEMENT DISORDERS
- Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes
- (2017) Laura Scott et al. EXPERIMENTAL NEUROLOGY
- A Clinical and Molecular Genetic Study of 50 Families with Autosomal Recessive Parkinsonism Revealed Known and Novel Gene Mutations
- (2017) Shaghayegh Taghavi et al. MOLECULAR NEUROBIOLOGY
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
- (2017) Diana Chang et al. NATURE GENETICS
- Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy
- (2017) Christoph Potting et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deregulation of α-synuclein in Parkinson’s disease: Insight from epigenetic structure and transcriptional regulation of SNCA
- (2017) Subhrangshu Guhathakurta et al. PROGRESS IN NEUROBIOLOGY
- CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons
- (2017) Xiaobing Qing et al. Stem Cell Research
- A novel tool for monitoring endogenous alpha-synuclein transcription by NanoLuciferase tag insertion at the 3′end using CRISPR-Cas9 genome editing technique
- (2017) Sambuddha Basu et al. Scientific Reports
- An updated review of Parkinson's disease genetics and clinicopathological correlations
- (2016) M. Ferreira et al. ACTA NEUROLOGICA SCANDINAVICA
- DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology
- (2016) Ricardo Taipa et al. BRAIN
- Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases
- (2016) Jing Yao et al. HUMAN GENETICS
- Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson’s Disease
- (2016) Anamitra Ghosh et al. Journal of Neuroimmune Pharmacology
- Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function
- (2016) Brendan J. Floyd et al. MOLECULAR CELL
- Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression
- (2016) Frank Soldner et al. NATURE
- Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease
- (2016) Richard Gordon et al. NEUROBIOLOGY OF DISEASE
- Up-regulation of SNCA gene expression: implications to synucleinopathies
- (2016) L. Tagliafierro et al. NEUROGENETICS
- Challenges in detecting disease modification in Parkinson's disease clinical trials
- (2016) Dilan Athauda et al. PARKINSONISM & RELATED DISORDERS
- Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain
- (2016) Wen Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
- (2016) Richard Gordon et al. Nature Communications
- One-step generation of triple gene-targeted pigs using CRISPR/Cas9 system
- (2016) Xianlong Wang et al. Scientific Reports
- Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62
- (2016) Rowena DeJesus et al. eLife
- CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector
- (2016) Giridhar Murlidharan et al. Molecular Therapy-Nucleic Acids
- Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes
- (2016) Christopher M. Rose et al. Cell Systems
- p13 overexpression in pancreatic β-cells ameliorates type 2 diabetes in high-fat-fed mice
- (2015) Shintaro Higashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
- (2015) Michael Lazarou et al. NATURE
- Polyelectrolyte complexes of hTERT siRNA and polyethyleneimine: Effect of degree of PEG grafting on biological and cellular activity
- (2015) Fatemeh Safari et al. Artificial Cells Nanomedicine and Biotechnology
- Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference
- (2015) Masaki Takahashi et al. Molecular Therapy-Nucleic Acids
- Mutations in RAB39B Cause X-Linked Intellectual Disability and Early-Onset Parkinson Disease with α-Synuclein Pathology
- (2014) Gabrielle R. Wilson et al. AMERICAN JOURNAL OF HUMAN GENETICS
- HLA-DRAis associated with Parkinson's disease in Iranian population
- (2014) J. Jamshidi et al. International Journal of Immunogenetics
- Pig models of neurodegenerative disorders: Utilization in cell replacement-based preclinical safety and efficacy studies
- (2014) Dasa Dolezalova et al. JOURNAL OF COMPARATIVE NEUROLOGY
- RIT2 , a susceptibility gene for Parkinson's disease in Iranian population
- (2014) Babak Emamalizadeh et al. NEUROBIOLOGY OF AGING
- Higher Vulnerability and Stress Sensitivity of Neuronal Precursor Cells Carrying an Alpha-Synuclein Gene Triplication
- (2014) Adrian Flierl et al. PLoS One
- Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection
- (2014) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Parkinson’s disease: animal models and dopaminergic cell vulnerability
- (2014) Javier Blesa et al. Frontiers in Neuroanatomy
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- A DNA Methyltransferase Inhibitor, 5-Aza-2′-Deoxycytidine, Exacerbates Neurotoxicity and Upregulates Parkinson's Disease-Related Genes in Dopaminergic Neurons
- (2013) Yong Wang et al. CNS Neuroscience & Therapeutics
- Hexokinase activity is required for recruitment of parkin to depolarized mitochondria
- (2013) Melissa K. McCoy et al. HUMAN MOLECULAR GENETICS
- Recent advances in Parkinson’s disease genetics
- (2013) Steven Lubbe et al. JOURNAL OF NEUROLOGY
- Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease
- (2013) San-xi Ai et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction
- (2013) Laurie H. Sanders et al. NEUROBIOLOGY OF DISEASE
- Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling
- (2013) Peter Reinhardt et al. PLoS One
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels
- (2013) Limin Shi et al. Nature Communications
- Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
- (2012) Blake Byers et al. Current Neurology and Neuroscience Reports
- Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
- (2012) Adriana Sánchez-Danés et al. EMBO Molecular Medicine
- Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q
- (2012) Michal Dekel-Naftali et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Increased Expression of Alpha-Synuclein by SNCA Duplication is Associated with Resistance to Toxic Stimuli
- (2012) Han-Joon Kim et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation
- (2012) Richard Gordon et al. Journal of Neuroinflammation
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease
- (2011) J. Zou et al. BLOOD
- An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons
- (2011) Christina E. Khodr et al. BRAIN RESEARCH
- LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
- (2011) Ha Nam Nguyen et al. Cell Stem Cell
- Modelling of Parkinson's disease in mice
- (2011) Marie-Françoise Chesselet et al. LANCET NEUROLOGY
- Parkinson's disease and α-synuclein expression
- (2011) Michael J. Devine et al. MOVEMENT DISORDERS
- Somatic coding mutations in human induced pluripotent stem cells
- (2011) Athurva Gore et al. NATURE
- Copy number variation and selection during reprogramming to pluripotency
- (2011) Samer M. Hussein et al. NATURE
- Next-Generation Sequencing Reveals Regional Differences of the α-Synuclein Methylation State Independent of Lewy Body Disease
- (2011) L. de Boni et al. NEUROMOLECULAR MEDICINE
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
- (2011) Laura A. Volpicelli-Daley et al. NEURON
- PINK1-linked parkinsonism is associated with Lewy body pathology
- (2010) Lluís Samaranch et al. BRAIN
- Short DNA sequences inserted for gene targeting can accidentally interfere with off-target gene expression
- (2010) Ingo D. Meier et al. FASEB JOURNAL
- Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update
- (2010) Karen Nuytemans et al. HUMAN MUTATION
- Methylation Regulates Alpha-Synuclein Expression and Is Decreased in Parkinson's Disease Patients' Brains
- (2010) A. Jowaed et al. JOURNAL OF NEUROSCIENCE
- In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration
- (2010) Oleg S Gorbatyuk et al. MOLECULAR THERAPY
- Ghrelin Stimulation of Growth Hormone-Releasing Hormone Neurons Is Direct in the Arcuate Nucleus
- (2010) Guillaume Osterstock et al. PLoS One
- α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra
- (2010) Alison L. McCormack et al. PLoS One
- CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson's Disease
- (2010) Lumine Matsumoto et al. PLoS One
- Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson's Patients with Neural Transplants
- (2010) M. Politis et al. Science Translational Medicine
- Lewy body pathology in fetal grafts
- (2009) Yaping Chu et al. Annals of the New York Academy of Sciences
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
- (2009) Juliane Neumann et al. BRAIN
- LRRK2 in Parkinson’s disease: biochemical functions
- (2009) Vasanti S. Anand et al. FEBS Journal
- Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial Mechanism
- (2009) Z. B. Andrews et al. JOURNAL OF NEUROSCIENCE
- Differential activation of PKCδ in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesions
- (2008) Katharine Hanrott et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Ancient Origin of the Parkinson Disease Gene LRRK2
- (2008) Ignacio Marín JOURNAL OF MOLECULAR EVOLUTION
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
- (2008) Jia-Yi Li et al. NATURE MEDICINE
- Elevated α-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease
- (2008) Jan Gründemann et al. NUCLEIC ACIDS RESEARCH
- Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes
- (2008) Kazuko Hasegawa et al. PARKINSONISM & RELATED DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now